Mathiesen, J. S., Kroustrup, J. P., Vestergaard, P.
, Stochholm, K., Poulsen, P. L., Rasmussen, Å. K., Feldt-Rasmussen, U.
, Schytte, S., Londero, S. C., Pedersen, H. B., Hahn, C. H., Bentzen, J., Möller, S.
, Gaustadnes, M., Rossing, M., Nielsen, F. C., Brixen, K., Frederiksen, A. L., Godballe, C. & Danish Thyroid Cancer Group (DATHYRCA) (2019).
Completeness of RET testing in patients with medullary thyroid carcinoma in Denmark 1997-2013: a nationwide study.
Clinical Epidemiology,
11, 93-99.
https://doi.org/10.2147/CLEP.S183268
McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H.
, Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., Wiviott, S. D., de Villiers, T., Ling, X., Lippuner, K., Nakamura, T., Reginster, J. Y., Rodriguez-Portales, J. A., Roux, C., Zanchetta, J. ... LOFT Investigators (2019).
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
The Lancet Diabetes and Endocrinology,
7(12), 899-911.
https://doi.org/10.1016/S2213-8587(19)30346-8